Chronic Lymphocytic Leukemia (CLL) Latest Advances

Find the Latest Research About Chronic Lymphocytic Leukemia (CLL)

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24827 publications

The spectrum of tonsillar involvement in chronic lymphocytic leukemia (CLL).

The spectrum of tonsillar involvement in chronic lymphocytic leukemia (CLL).

Journal: Leukemia & lymphoma
Published: January 20, 2026

Diffuse Calcified Lymphadenopathy in Untreated Small Lymphocytic Lymphoma.

Diffuse Calcified Lymphadenopathy in Untreated Small Lymphocytic Lymphoma.

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: January 20, 2026

Prolonged progression-free survival with zanubrutinib in relapsed/refractory CLL: an indirect treatment comparison versus other BTK inhibitors using multilevel network meta-regression.

Prolonged progression-free survival with zanubrutinib in relapsed/refractory CLL: an indirect treatment comparison versus other BTK inhibitors using multilevel network meta-regression.

Journal: Journal of medical economics
Published: January 19, 2026

Can minimal residual disease be used to tailor therapy duration for chronic lymphocytic leukemia patients?

Can minimal residual disease be used to tailor therapy duration for chronic lymphocytic leukemia patients?

Journal: Expert review of hematology
Published: January 18, 2026

Prospective patient preference study for Bruton tyrosine kinase inhibitor (BTKi) treatment attributes and factors affecting patient shared decision-making in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) in the United States (US).

Prospective patient preference study for Bruton tyrosine kinase inhibitor (BTKi) treatment attributes and factors affecting patient shared decision-making in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) in the United States (US).

Journal: Expert review of hematology
Published: January 13, 2026

Expression of Type 2 Innate Lymphoid Cell and IL-9 and Other Related Cytokines in Chronic Lymphocytic Leukemia

Expression of Type 2 Innate Lymphoid Cell and IL-9 and Other Related Cytokines in Chronic Lymphocytic Leukemia

Journal: Zhongguo shi yan xue ye xue za zhi
Published: January 08, 2026

Identification of Central Genes in the Pathogenesis of Lipid Metabolism in Chronic Lymphocytic Leukaemia: A Multi-Omics Study Integrating Machine Learning and Mendelian Randomisation.

Identification of Central Genes in the Pathogenesis of Lipid Metabolism in Chronic Lymphocytic Leukaemia: A Multi-Omics Study Integrating Machine Learning and Mendelian Randomisation.

Journal: Cell biochemistry and biophysics
Published: January 05, 2026

Beyond CKD-Associated Pruritus: Paraneoplastic Itch Revealing CLL/SLL in ESRD: A Case Report.

Beyond CKD-Associated Pruritus: Paraneoplastic Itch Revealing CLL/SLL in ESRD: A Case Report.

Journal: The American journal of case reports
Published: December 30, 2025

A real-world study evaluating drug tolerability and health care resource use with acalabrutinib vs ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

A real-world study evaluating drug tolerability and health care resource use with acalabrutinib vs ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

Journal: Journal of medical economics
Published: December 27, 2025

Bilateral Nongranulomatous Anterior Uveitis with Macular Edema Associated with Ibrutinib Use: A Case Report.

Bilateral Nongranulomatous Anterior Uveitis with Macular Edema Associated with Ibrutinib Use: A Case Report.

Journal: Ocular immunology and inflammation
Published: December 23, 2025

New BTK Inhibitors May Combat Resistance in CLL.

New BTK Inhibitors May Combat Resistance in CLL.

Journal: Cancer discovery
Published: December 22, 2025

Patterns of Bruton's Tyrosine Kinase Inhibitor (BTKi) Usage in B-cell Lymphomas in India: A Questionnaire-Based Study.

Patterns of Bruton's Tyrosine Kinase Inhibitor (BTKi) Usage in B-cell Lymphomas in India: A Questionnaire-Based Study.

Journal: Cureus
Published: December 21, 2025
Showing 1-12 of 24,827

Last Updated: 02/24/2026